Your browser doesn't support javascript.
loading
Highly potent and selective cannabinoid receptor 2 agonists: initial hit optimization of an adamantyl hit series identified from high-through-put screening.
Nettekoven, Matthias; Fingerle, Jürgen; Grether, Uwe; Grüner, Sabine; Kimbara, Atsushi; Püllmann, Bernd; Rogers-Evans, Mark; Röver, Stephan; Schuler, Franz; Schulz-Gasch, Tanja; Ullmer, Christoph.
Afiliación
  • Nettekoven M; F. Hoffmann-La Roche Ltd, Pharma Research & Early Development, Medicinal Chemistry, Grenzacher Str. 124, 4070 Basel, Switzerland. matthias.nettekoven@roche.com
Bioorg Med Chem Lett ; 23(5): 1177-81, 2013 Mar 01.
Article en En | MEDLINE | ID: mdl-23380378
ABSTRACT
A series of highly potent & selective adamantane derived CB2 agonists was identified in a high-throughput screen. A SAR was established and physicochemical properties were significantly improved. This was accompanied by potency of the compounds on the Q63R variant and varying ß-arrestin data which will support the insight into their relevance for the in vivo situation.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Adamantano / Receptor Cannabinoide CB2 / Agonistas de Receptores de Cannabinoides Tipo de estudio: Diagnostic_studies / Screening_studies Límite: Humans Idioma: En Revista: Bioorg Med Chem Lett Asunto de la revista: BIOQUIMICA / QUIMICA Año: 2013 Tipo del documento: Article País de afiliación: Suiza

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Adamantano / Receptor Cannabinoide CB2 / Agonistas de Receptores de Cannabinoides Tipo de estudio: Diagnostic_studies / Screening_studies Límite: Humans Idioma: En Revista: Bioorg Med Chem Lett Asunto de la revista: BIOQUIMICA / QUIMICA Año: 2013 Tipo del documento: Article País de afiliación: Suiza
...